PT3632909T - Sal e forma cristalina de composto de andrografólido modificado e seu método de preparação - Google Patents
Sal e forma cristalina de composto de andrografólido modificado e seu método de preparaçãoInfo
- Publication number
- PT3632909T PT3632909T PT188058937T PT18805893T PT3632909T PT 3632909 T PT3632909 T PT 3632909T PT 188058937 T PT188058937 T PT 188058937T PT 18805893 T PT18805893 T PT 18805893T PT 3632909 T PT3632909 T PT 3632909T
- Authority
- PT
- Portugal
- Prior art keywords
- salt
- modified
- preparation
- crystal form
- andrographolide compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710373576 | 2017-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3632909T true PT3632909T (pt) | 2023-09-27 |
Family
ID=64396260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT188058937T PT3632909T (pt) | 2017-05-24 | 2018-05-24 | Sal e forma cristalina de composto de andrografólido modificado e seu método de preparação |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11299482B2 (pt) |
| EP (1) | EP3632909B1 (pt) |
| CN (1) | CN110650953B (pt) |
| ES (1) | ES2955294T3 (pt) |
| PT (1) | PT3632909T (pt) |
| WO (1) | WO2018214929A1 (pt) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3209658A1 (en) * | 2014-10-24 | 2017-08-30 | Biogen MA Inc. | Diterpenoid derivatives and methods of use thereof |
| CN105367558B (zh) | 2015-08-27 | 2018-07-03 | 沈阳药科大学 | 穿心莲内酯衍生物及其制备方法和用途 |
| WO2017088738A1 (zh) | 2015-11-26 | 2017-06-01 | 南京明德新药研发股份有限公司 | 穿心莲内酯改构化合物 |
| CN106800551B (zh) | 2015-11-26 | 2021-05-11 | 黑龙江珍宝岛药业股份有限公司 | 穿心莲内酯改构化合物 |
-
2018
- 2018-05-24 WO PCT/CN2018/088168 patent/WO2018214929A1/zh active Application Filing
- 2018-05-24 EP EP18805893.7A patent/EP3632909B1/en active Active
- 2018-05-24 ES ES18805893T patent/ES2955294T3/es active Active
- 2018-05-24 PT PT188058937T patent/PT3632909T/pt unknown
- 2018-05-24 US US16/616,300 patent/US11299482B2/en active Active
- 2018-05-24 CN CN201880033723.8A patent/CN110650953B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2955294T3 (es) | 2023-11-29 |
| CN110650953B (zh) | 2023-01-10 |
| CN110650953A (zh) | 2020-01-03 |
| EP3632909A1 (en) | 2020-04-08 |
| WO2018214929A1 (zh) | 2018-11-29 |
| EP3632909A4 (en) | 2020-12-23 |
| US11299482B2 (en) | 2022-04-12 |
| US20210284630A1 (en) | 2021-09-16 |
| EP3632909B1 (en) | 2023-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3287444A4 (en) | New crystal form of lenvatinib methanesulfonate salt and preparation method thereof | |
| GB201514756D0 (en) | Compound and method of use | |
| IL252691A0 (en) | A method for producing crystals of a diazabicyclooctane derivative and a stable lyophilized preparation | |
| IL250290A0 (en) | A salt of a monocyclic pyridine derivative and its crystalline form | |
| EP3453703A4 (en) | CRYSTALLINE FORM OF TAFAMIDIS-METHYLGLUCAMINE SALT AND MANUFACTURING METHOD AND APPLICATION THEREOF | |
| HK1256860A1 (zh) | 喹唑啉衍生物的晶體及其製備方法 | |
| EP3502103A4 (en) | CRYSTALLINE FORM, TYPE OF SALT OF A SUBSTITUTED 2-HYDRO-PYRAZOLE DERIVATIVE AND PREPARATION METHOD THEREOF | |
| EP3502100A4 (en) | CRYSTAL FORMS OF OZANIMOD AND MANUFACTURING METHOD THEREFOR | |
| EP3239149A4 (en) | Crystal form i of canagliflozin and preparation method thereof | |
| LT3327012T (lt) | Bilastino kristalinės formos ir jų gamybos būdai | |
| PT3725786T (pt) | Forma cristalina e forma salina de inibidor de tgf-bri e método de preparação das mesmas | |
| EP3369733A4 (en) | Crystal form of 4h-pyrazolo[1,5- ]benzoimidazole compound, preparation method therefor and intermediate thereof | |
| PL3330267T3 (pl) | Sól pochodnej chinazoliny lub jej kryształ oraz sposób wytwarzania soli pochodnej chinazoliny lub jej kryształu | |
| EP3272751A4 (en) | Crystal form of ipi-145 and preparation method thereof | |
| ZA202004055B (en) | Salt of phenylpropionamide derivative and preparation method therefor | |
| IL263868A (en) | Crystal structures of aminomethyl-converted tetracyclines and processes for their preparation | |
| EP3269710A4 (en) | Nintedanib diethanesulfonate salt crystal and preparation method and use thereof | |
| HK1252375A1 (zh) | 喹唑啉衍生物的晶體及其製備方法 | |
| HK1258757A1 (zh) | 4H-吡唑並[1，5-α]苯並咪唑類化合物的鹽型、晶型及其製備方法和中間體 | |
| HK1244807A1 (zh) | 咪唑衍生物及其中間體的製備方法和晶型 | |
| IL274274A (en) | Salt form and crystal form of compound as FGFR4 inhibitor and method of their preparation | |
| ZA202007037B (en) | Crystal form of c-met inhibitor and salt form thereof and preparation method therefor | |
| ZA202101589B (en) | Crystal form of tri-cycle compound and application thereof | |
| EP3302099A4 (en) | Enhanced salt compositions and methods of preparation thereof | |
| ZA202003581B (en) | Crystal form of urat1 inhibitor, and preparation method therefor |